Three Phase 3 trials hit their primary endpoints in the span of two weeks. The stock is sitting roughly a...

Delta Air Lines posted September quarter revenue of $17.6 billion, up 16 percent from the prior year, but the airline's...

Before anything else The 10-K for fiscal year 2025 shows Zoetis earning its widest net margin in five years, keeping...

Viatris agreed to acquire Pacira BioSciences for $36.50 per share in cash, an aggregate equity value of $1.65 billion, adding...

PepsiCo's third-quarter organic revenue growth jumped to 3.1%, up from 2.7% year-to-date, driven by volume gains across international marke

The share price is up 72% over the past twelve months. Revenue has fallen every single year since 2021. Those...

A stock sitting well below its 52-week high while posting the best operating margin in at least seven years. Those...

In one breath Organogenesis built a $564 million business selling advanced wound-care products to Medicare patients, then watched a single...

Regeneron spent most of 2024 and 2025 telling investors a story about transition: EYLEA, its aging eye-injection blockbuster, was losing...

Caribou Biosciences announced it is evaluating strategic alternatives, including a merger or sale, and will discontinue development of its